Status
Conditions
Treatments
Study type
Identifiers
About
Testing of a new ready-to-use Tape in comparison to the currently used skin prick test for the diagnosis of allergies. Assessment of clinical equivalence of the SPT Tape for representative common inhalant allergens to conventional SPT in terms of wheal reaction positivity and overall safety. Tests are performed in patients who have a medical history of relevant allergic rhinitis to any of the tested allergens.
Full description
An open-label, single site bridging study. Subjects with a history of in-halation allergies will be tested in parallel with the SPT Tape and with the conventional SPT procedure using one forearm each.
In each patient, a panel of 8 allergens with the SPT Tape and with the conventional SPT is applied on the two forearms one time only.
The following Soluprick® allergens and control solutions will be evaluated:
Positive control, negative control, Phleum pratense, birch, Dermatophagoides pteronyssinus, D. farinae, dog dander, cat dander, mugwort, Alternaria sp. The allergens used for the SPT and the SPT Tape are identical Soluprick allergen solutions; allergens will be applied in the same location and order on both arms.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Subjects will be included only, if
Exclusion criteria
Subjects may not be included, if
they are impaired in understanding nature, meaning, and the scope of the study, or are incapable of giving written informed consent,
they suffer from diseases, show other conditions, or take medications, which might impact the skin tests or might contradict the correct conduct and evaluation of the study. In particular this includes the following:
Primary purpose
Allocation
Interventional model
Masking
75 participants in 2 patient groups
Loading...
Central trial contact
Claus U Bachert, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal